Sheryl Beauchamp

Sheryl Beauchamp currently serves as Sr. Director of PMO & Business Excellence in Clinical Safety & Pharmacovigilance at Daiichi Sankyo, Inc. since August 2022. Prior roles include Director positions at Bristol Myers Squibb focused on Medical Review and Project Management, and Director of Project Management Drug Safety at Celgene. Earlier experience encompasses strategic planning and portfolio management at Eisai US, and R&D consulting at Accenture. Initial professional experience includes co-op roles at ImClone Systems, Boston Scientific, and Ethicon, contributing to manufacturing technologies and packaging engineering. Sheryl holds a Bachelor's degree in Chemical Engineering with a minor in Biochemical Engineering from Stevens Institute of Technology, along with a Graduate Certificate in Pharmaceutical Manufacturing.